GLP-1 diet videos: what 'clean eating' advice gets wrong

What's this video probably claiming?

Based on the caption and hashtag stack, this is almost certainly a "what I eat in a day" video from someone using a GLP-1 medication, most likely semaglutide or tirzepatide. The creator is probably showing simplified, high-protein meals and possibly discussing caffeine intake, framing her eating pattern as a model for others on GLP-1 therapy. The #cleaneating tag suggests she's positioning certain foods as inherently better choices on these medications. The #comfortfood tag implies she's trying to show that GLP-1 eating doesn't have to be restrictive or joyless. These videos typically carry an implicit message: eat like me, get results like me. That's where things get medically complicated, fast.

What does the science actually show?

The protein emphasis is probably the most defensible part of this type of content. Studies on GLP-1 receptor agonists consistently show that lean mass loss is a real concern during rapid weight reduction. A 2021 trial by Wilding et al. in the New England Journal of Medicine found that semaglutide 2.4 mg weekly produced about 14.9% body weight loss over 68 weeks, but roughly 39% of that loss came from lean tissue in some analyses. Prioritizing dietary protein, somewhere in the range of 1.2 to 1.6 grams per kilogram of body weight daily, is a legitimate clinical strategy to offset this. The caffeine angle is less clear. Caffeine does modestly suppress appetite, but its interaction with GLP-1-driven nausea hasn't been well-studied in randomized trials. Gastric emptying is already slowed by these drugs, and caffeine's effect on an already-sensitive GI tract is not neutral.

Where does the social media noise diverge from clinical reality?

The biggest problem with "what I eat in a day" GLP-1 content isn't usually what's said. It's what's left out. Individual response to semaglutide and tirzepatide varies enormously. Wilding et al. 2021 reported a standard deviation wide enough that some participants lost less than 5% of body weight at the same dose. A meal pattern that works for someone with strong appetite suppression may be genuinely inadequate for someone with a milder response. The #cleaneating framing also tends to moralize food in a way that conflicts with evidence-based nutrition counseling. Davies et al. 2021 in The Lancet, covering liraglutide, found that structured behavioral support, not food purity ideology, was the factor most associated with sustained outcomes. Caffeine specifically: heavy intake can worsen GLP-1-associated nausea and acid reflux, effects that are common enough that they drove discontinuation in roughly 7% of trial participants in the SURMOUNT-1 tirzepatide trial (Jastreboff et al., NEJM, 2022).

What should you actually know?

If you're on a GLP-1 medication and watching these videos for guidance, here's the clinical reality check. Protein intake matters, but the specific foods shown by any one creator are not a protocol. Your caloric needs on these medications are highly individual and should be determined with a registered dietitian, not a TikTok feed. The "keep it simple" framing is appealing but can mask under-eating, which is a documented risk on GLP-1 therapy. A 2023 paper by Aronne et al. in Obesity emphasized that patients on semaglutide who ate fewer than 1,000 calories daily without supervision showed higher rates of muscle loss and micronutrient deficiency. Caffeine in moderate amounts is generally fine for most people, but if you're experiencing nausea on your medication, it's worth being honest with your prescriber about your intake. And no, someone's meal aesthetic on social media is not a substitute for a clinical nutrition plan.